An international team of radiation oncologists are helping to protect patients and providers and conserve protective equipment for frontline health care workers during the COVID-19 pandemic.

To limit exposure of COVID-19 to pregnant patients, Michigan Medicine unveils a new prenatal care approach.

Even before scientists understood what caused them, or developed drugs or vaccines for them, U-M offered advanced care for infectious diseases.

The latest stories from the Michigan Health and the Michigan Health Lab on the coronavirus outbreak.

Dental patients who receive opioids after getting a tooth pulled have no less pain, and no more patient satisfaction, than those who receive non-opioid painkillers.

An epidemiologist explains the term "R0" and how many people one person can infect if they have the coronavirus.

Disruptions in insurance coverage disproportionately affect racial and ethnic minority women before, during and after pregnancy.

A new Michigan Medicine study finds an increase in treatments for rare diseases affecting kids.

Rare Disease Day is celebrated across the globe to raise awareness about rare diseases and how they impact patients’ lives. Michigan Medicine is working to better understand the mechanisms behind these rare diseases.

A new study on drug pricing found higher costs resulted in neurology patients being less likely to take their prescribed medications.

Cervical cancer is considered preventable in its early stages, but without breaking down barriers to prevention, women in certain countries remain at high risk.

For children diagnosed with high risk brain tumors, an exclusive global network helps promising clinical trials underway.

Hospital choice, higher maternal BMI and larger baby size increase chances of cesarean deliveries, according to an abstract presented at the Society of Maternal-Fetal Medicine’s annual Pregnancy Meeting.

A doctor develops a new training program to help improve testing and care available for those with the genetic disease, starting in the Middle East.

Researchers report endogenous immunotoxin that could potentially be used as biomarker for predicting kidney disease.